Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Das 13-Millionen-Unternehmen mit einer Monster-Entdeckung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
251 Leser
Artikel bewerten:
(1)

Antimicrobial Technologies - IDTechEx Discusses How They Work

Finanznachrichten News

BOSTON, April 8, 2021 /PRNewswire/ -- Antimicrobial technologies such as coatings and textiles containing silver and copper are helping people during the COVID-19 pandemic by ensuring that whatever they touch, whether that is a door handle or their own mask, is free from live SARS-CoV-2 particles. But how exactly do these antimicrobial technologies work? How can a silver, copper or even polymeric coating kill microorganisms such as bacteria, fungi, or in the case of COVID-19, viruses? This article explores the mechanisms of action, or the interactions, through which antimicrobials work. IDTechEx have recently published a research report on the antimicrobial technology industry - "Antimicrobial Technology Market 2021- 2031". Please refer to www.IDTechEx.com/Antimicrobial for more information.

IDTechEx has found that a large portion of antimicrobial companies are developing silver-based technologies. Source: IDTechEx -

Damaging cell walls and membranes

Microorganisms such as bacteria, viruses, and mold are single cellular organisms surrounded by either a cell wall, cell membrane, or both. Disruption of this outside layer is a common way to kill microorganisms. Like all organisms, the insides of a microorganism are carefully regulated, and ideally, stays inside.

One way to destroy microorganisms is to disrupt the activity of the membrane. For example, silver-based technologies release silver ions that can bind to proteins within the membrane that regulate transport into and out of the cell. Similarly, high concentrations of zinc, itself essential to microorganisms for growth, can end up blocking ion channels that cross the membrane. When nutrients essential to the microorganism cannot enter, cell growth and reproduction is halted.

A more drastic method is to simply break the microorganism open. A wide range of antimicrobial technologies generate reactive oxygen species such as peroxides and singlet oxygen that attack and break down the cell membrane. Others, such as silane quaternary compounds, simply pierce or rupture the membrane through mechanical means.

Binding and inhibiting essential cellular processes

Antimicrobial technologies can also wreak havoc from inside the cell. Metal-based technologies, such as silver, copper, and zinc, release ions that bind to components of the cell's internal machinery, many of which are a part of pathways essential to the cell's survival. Metallic ions, being positively charged, also interact with negatively charged genetic material such as DNA and RNA. Access to DNA and RNA is critical - without it, new proteins cannot be created, and in the case of DNA, cell division is halted when DNA cannot be copied.

Preventing adhesion to surfaces

A tactic to combat bacteria and mold is to simply prevent adherence to surfaces. Bacteria and mold have the ability to form biofilm, a dense film-like structure containing and protecting millions of microorganisms. The first step to forming biofilm, is adherence to a surface. Antimicrobial companies have created surfaces that provide an unfavorable environment for adhesion, resulting in a microorganism that simply lives out the rest of its short life in peace without growing and forming problematic films.

Does the mechanism of action matter?

In short, yes!

There is a great concern amongst scientists that antimicrobials that kill microorganisms from within can contribute to the development of antibiotic resistant bacteria. Almost all organisms have a mechanism called an efflux pump that is responsible for removing toxic substances. Extensive exposure to low levels of toxins pressures microorganisms to develop and evolve more effective efflux pumps, which the microorganism can also use to pump out antibiotics.

As far, scientists have only managed to induce resistance to antimicrobial technologies in the laboratory, but it will become a possibility in the wild if antimicrobial technologies are used irresponsibly. Antibiotic resistance is deemed by the World Health Organization as one of the top 10 global public health threats facing humanity - without effective antibiotics, many routine conditions and medical procedures today will become a matter of life and death.

IDTechEx have analyzed over 100 companies in the antimicrobial technology market, many of which are developing technologies to circumvent the problem of antimicrobial resistance. For more information on the topic, please refer to www.IDTechEx.com/Antimicrobial, or for the full portfolio of Healthcare related research available from IDTechEx please visit www.IDTechEx.com/Research/Healthcare.

About IDTechEx

IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact research@IDTechEx.com or visit www.IDTechEx.com.

Images download:
https://www.dropbox.com/sh/xf9c47qzkbpcwow/AACpeOD5W0hJ9OFdh1vbgqRla?dl=0

Media Contact:

Natalie Moreton
Digital Marketing Manager
press@IDTechEx.com
+44(0)1223 812300

Social Media Links:

Twitter: https://www.twitter.com/IDTechEx
LinkedIn: https://www.linkedin.com/company/idtechex/
Facebook: https://www.facebook.com/IDTechExResearch

IDTechEx Logo

Photo: https://mma.prnewswire.com/media/1483828/IDTechEx_Antimicrobial_products.jpg

Logo: https://mma.prnewswire.com/media/478371/IDTechEx_Logo.jpg

© 2021 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.